Administration of berberine metabolites
AssigneeKeto Patent Group, Inc.
InventorsRyan Lowery, Jacob Wilson, Terry LaCore
Life of this patent
Estimating the term…
Abstract
In various implementations, berberine metabolites, such as dihydroberberine and/or tetrahydroberberine, may be administered to manage blood glucose levels, increase ketone levels (e.g., blood concentration of ketones), and/or for therapeutic purposes in humans. The administration of a pharmaceutically effective amount of berberine metabolites, such as dihydroberberine, may reduce fasting blood glucose levels, improve glucose tolerance, and/or improve blood ketone response. In some implementations, berberine metabolites may be administered with one or more other compounds.
Claims7
A method of managing glucose tolerance in an individual, the method comprising:
- administering, to an individual a pharmaceutically effective amount of R-beta-hydroxybutyrate, wherein the pharmaceutically effective amount of R-beta-hydroxybutyrate comprises less than approximately 2 g of R-beta-hydroxybutyrate.
Dependencies are inferred from the claim text.